Adisseo to build new methionine plant in China
The total investment will come to RMB 4.9bn (US$681m), and the facility, which will be located at the Quanhui Petrochemical Industrial Zone, Quanzhou City, is expected to be operational in 2027.
As the site is adjacent to sister company, SinoChem, the project will benefit from supply chain synergies, optimizing capital investments and operating costs.
“This project will strengthen our leading position in the methionine industry as well as optimize our methionine product portfolios and global production capacity layout, thereby creating value for our customers,” commented Dr Zhigang Hao, chairman and CEO of Adisseo.
Cost competitiveness, economies of scale and a multi-asset model are fundamental to ongoing success in the global methionine market, noted the supplier.
Meeting emerging market demand
A subsidiary of China National BlueStar, Adisseo said it is aiming to be a frontrunner globally in the powder methionine market, noting strong demand for that product in China and developing markets.
The feed additive producer also outlined how sustainability and digitalization goals would inform the project. It is aiming to build a “greener, smarter and more competitive plant.”
Adisseo's high volume, 180,000-ton-per-year, liquid methionine plant in Nanjing in China went online in September 2022; it is one of the world's largest liquid methionine production platforms.
